Stocks rallying after hitting the year’s lows as one central bank indicated it’s willing to step in to calm the markets. But will the Fed follow suit or is there more turmoil ahead? Plus Biogen making a major breakthrough with its Alzheimer’s treatment. What it means for the stock and the rest of the biotech space.

S&P 500 notches a new closing low for 2022. With yields up and stocks down, what’s ahead for the market? The Fast Money desk debates